{"nct_id":"NCT00455572","title":"Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer","status":"TERMINATED","status_verified_date":"2017-05","start_date":"2007-05-11","start_date_type":"ACTUAL","primary_completion_date":"2013-08-04","primary_completion_date_type":"ACTUAL","completion_date":"2013-08-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}